Hancock Whitney’s MiMedx Group MDXG Stock Holding History

Hancock Whitney’s Portfolio MDXG Stock Details MDXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-844,330	Closed	-$7.38K	–	599
2016 Q1	$7.38K	Buy	+844,330	New	+$7.02M	0.31%	144
2015 Q4	–	Sell	-772,170	Closed	-$7.45M	–	557
2015 Q3	$7.45M	Buy	+772,170	New	+$8.15M	0.31%	128

Other funds holding MDXG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Hancock Whitney's MDXG Position: Q2 2016 in Review

Hancock Whitney sold out of MiMedx Group (MDXG) in Q2 2016, closing a stake of 844,330 shares — an estimated $7.38K sold.

Hancock Whitney first reported a position in MDXG in Q3 2015 and held it in 2 quarters. The position peaked at $7.45M in Q3 2015. 181 funds tracked by Wall St. Rank hold MDXG as of Q2 2016.

Hancock Whitney reported no remaining MiMedx Group position as of Q2 2016 after selling out during the quarter.
Hancock Whitney sold 844,330 MiMedx Group shares in Q2 2016, an estimated $7.38K.
Hancock Whitney first reported a position in MiMedx Group in Q3 2015 and held it in 2 quarters.
Hancock Whitney's MiMedx Group position peaked at $7.45M in Q3 2015.
181 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2016.

Based on Hancock Whitney's 13F filing for Q2 2016, filed 9 Aug 2016.